Large gap with delayed quotes
|
Last quote
07/01/2025
-
12:30:37
|
Bid
07/01/2025 -
12:31:23
|
Bid Volume |
Ask
07/01/2025 -
12:34:41
|
Ask Volume |
|---|---|---|---|---|
|
29.80
-0.40
(
-1.32% )
|
29.70
|
2,678 |
29.85
|
1,317 |
Analysis date: 27.06.2025
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 27.06.2025.
Interest
Strong
Strong
Three stars since 17.06.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 17.06.2025 at a price of 29.45.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 03.06.2025.
4wk Rel Perf
4.61%
4.61%
The four-week dividend-adjusted overperformance versus STOXX600 is 4.61%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 27.05.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by 0.10%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.23%.
Mkt Cap in $bn
2.10
2.10
With a market capitalization between $2 & $8bn, BB BIOTECH AG is considered a mid-cap stock.
G/PE Ratio
15.15
15.15
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
5.21
5.21
The estimated PE is for the year 2025.
LT Growth
70.04%
70.04%
The annualized growth estimate is for the current year to 2025.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
8.94%
8.94%
The twelve month estimated dividend yield represents 46.59% of earnings forecasts.
Beta
104
104
For 1% of index variation, the stock varies on average by 1.04%.
Correlation
0.53
0.53
53.03% of stock movements are explained by index variations.
Value at Risk
3.30
3.30
The value at risk is estimated at CHF 3.30. The risk is therefore 10.80%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.07.2014
22.07.2014